Projecting Market Access Success For Early-Stage Pharma Assets: Getting Past The Hurdles.
- Resource Type
- Article
- Authors
- TOUCHOT, NICOLAS; NISHIDA, LYNN; FLUME, MATHIAS
- Source
- IN VIVO. Feb2013, Vol. 31 Issue 2, p58-98. 9p.
- Subject
- *VENTURE capital companies
*EXECUTIVES
*VENTURE capital
*ASSETS (Accounting)
*PHARMACEUTICAL industry
- Language
- ISSN
- 2160-9861
The article discusses how the adjustment of the early screening and evaluation process can help in the identification of indications and assets with high future market access potential. A survey of venture capital (VC) executives during the fourth quarter of 2012 showed that at one end, there were VCs that do not perform specific market access evaluation, while at the other end, there are those that systematically perform detailed market access evaluations. INSET: ALMIRALL TAKES THE LEAD.